Retinal cell cancer is a rare eye cancer that usually affects babies and young children. Early symptoms of retinal cell cancer can include a white glow in the pupil, an eye that turns inward or outward, or less often eye pain and redness. Many people only realize later that their symptoms were connected to retinal cell cancer. It needs prompt treatment because it can threaten vision and can become life threatening if it spreads, but survival is often very good when it is found early. Treatment often includes laser treatment, freezing treatment, chemotherapy, and sometimes surgery to remove the eye.
How many people live with Retinal cell cancer?
There is no single widely accepted count of how many people are living with retinal cell cancer, usually called retinoblastoma, worldwide or in the United States, because most sources track new cases in children rather than everyone living after treatment. The numbers most often reported are about 8,000 new cases worldwide each year (National Cancer Institute, 2024) and about 250 new cases each year in the United States (National Cancer Institute, 2024).
Overview
Retinal cell cancerSymptoms
Retinal cell cancer often causes a white glow in the pupil in photos, an eye that turns inward or outward, or vision problems. Some children also have eye redness or swelling, though early signs can vary.
Outlook and prognosis
Retinal cell cancer often has an excellent outlook when found early, and most children can survive with timely treatment. Vision outcomes vary, especially if one eye is more affected, but close follow-up helps catch treatment effects or rare recurrence early.
Causes and risk factors
Retinal cell cancer usually starts from a change in the RB1 gene, often before birth. It may be inherited from a parent or happen new; family history is the main risk factor, while lifestyle or environmental causes are not established.
Genetic influences
Genetics are very important in retinal cell cancer. Changes in the RB1 gene cause many cases, especially in children, and inherited changes can raise risk, affect both eyes, and matter for family testing and future planning.
Diagnosis
Doctors diagnose retinal cell cancer with a dilated eye exam, eye imaging such as ultrasound or MRI, and sometimes genetic testing. Diagnosis often starts after white pupil reflex, crossed eyes, or vision concerns are noticed.
Treatment and drugs
Treatment for retinal cell cancer often aims to save vision and prevent spread. Depending on the tumor, care may include laser or freezing treatment, chemotherapy, targeted radiation, or surgery, sometimes using more than one approach.
Symptoms
Retinal cell cancer, often called retinoblastoma, usually shows up through changes in a child’s eyes or vision rather than pain or feeling unwell. The most common clue is a white glow in the pupil, especially in photos, though some children develop a squint or vision changes instead. Loved ones often notice the changes first. Early features of retinal cell cancer can be subtle, and some children have only one sign at first.
A white, pale, or yellow glow in the pupil is the most common sign. It often stands out in flash photos, where one eye looks white instead of showing the usual red-eye effect.
One eye may drift inward or outward because the eyes are no longer lining up well together. Many living with retinal cell cancer are first noticed to have this while looking at faces, toys, or books.
Some children do not track objects well or seem to see less clearly with one eye. This can show up as missing a toy when reaching, bumping into things, or sitting very close to screens or books.
Less often, the eye can look red, irritated, or swollen, and some children seem bothered by bright light. This may happen when retinal cell cancer raises pressure in the eye or causes inflammation.
How people usually first notice Retinal cell cancer?
Retinal cell cancer, usually called retinoblastoma, is often first noticed when a baby or young child’s pupil looks white instead of red in photos, especially in flash pictures, or when one eye seems to drift or cross. Some families also notice the first signs of retinal cell cancer as unusual eye movement, poor tracking of faces or toys, or less often redness and swelling that do not go away. In many children, doctors first spot how retinal cell cancer is first noticed during a routine eye exam, and in some cases it can even be suspected before birth or soon after delivery if there is a strong family history.
Types of Retinal cell cancer
Retinal cell cancer, often called retinoblastoma, can show up in a few well-recognized forms. In practice, the main types of retinal cell cancer are based on whether one eye or both eyes are affected, and whether there is also a related tumor in the brain. Symptoms don’t always look the same for everyone. Many people first notice a white glow in the pupil in photos, a wandering eye, or vision changes, but the pattern can differ by type.
Unilateral
This type affects one eye only and is the most common form. Many children are brought in after a parent notices a white pupil in flash photos, an eye that turns inward or outward, or reduced vision in one eye. It is often not inherited, though doctors still check carefully because exceptions can occur.
Bilateral
This type affects both eyes and is more often linked to an inherited gene change. It is usually found at a younger age than unilateral disease, and vision problems may involve both eyes rather than just one. The number, size, and location of tumors can differ between the two eyes.
Trilateral
This is a rare variant in which retinoblastoma occurs in the eye or eyes along with a similar tumor in the brain, usually near the pineal gland. Along with eye signs, children may develop symptoms such as headaches, vomiting, unusual sleepiness, or other signs of increased pressure in the head. Having one type doesn’t necessarily mean you’ll develop the others, but this form is watched for in children with inherited retinoblastoma.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or medicines can meaningfully delay the start of symptoms in retinal cell cancer, because this rare eye cancer is usually caused by gene changes that happen before birth or very early in childhood. Diet, exercise, sleep, or supplements have not been shown to prevent it or push symptoms back, although research is ongoing; what matters most is early detection, especially for babies and children with a family history, who should have regular eye exams as advised by their doctor. That cannot guarantee prevention, but finding it early can make treatment easier and may help protect sight.
What genetics can tell you about symptoms
Yes. In retinal cell cancer, changes in the RB1 gene can affect how the condition shows up: children born with an RB1 change are more likely to develop cancer at a younger age, sometimes in both eyes and sometimes with more than one tumor, while children without an inherited RB1 change often have just one tumor in one eye. Genetics cannot predict every symptom, but it can give useful clues about when the cancer may begin and how closely doctors need to watch for eye problems such as a white pupil, crossed eyes, or changes in vision.
Causes and risk factors
Most retinal cell cancer, medically called retinoblastoma, is caused by a change in the RB1 gene. Some children inherit this gene change from a parent, and in others it happens for the first time very early in development. The main risk factors for retinal cell cancer are family history and very young age, since it usually affects babies and young children. There are no well-proven links to diet, exercise, or common environmental exposures, and most cases are not caused by anything a parent did during pregnancy or early childhood. Knowing your family history is a good first step if you are worried about genetic causes of retinal cell cancer.
What are the most common causes or risk factors?
The most common cause of retinal cell cancer, also called retinoblastoma, is a change in a gene called RB1, which normally helps keep cell growth under control in the retina, the light-sensing tissue at the back of the eye. These gene changes can be passed down in families or can happen by chance very early in a child’s development, so the biggest risk factors are a family history of the disease and being a very young child, usually under age 5. Unlike many adult cancers, clear lifestyle or environmental risk factors have not been strongly linked to this cancer.
Environmental and biological risk factors
Retinal cell cancer usually begins from changes that happen very early in a child’s development, so families often did nothing to cause it. Doctors often group risks into internal (biological) and external (environmental). For retinal cell cancer, the strongest known risks are biological, and well-proven environmental risks are limited.
Most cases appear in babies and young children, which shows the risk is highest during early eye development. This is one of the clearest biological patterns seen with retinal cell cancer.
In many children, retinal cell cancer is linked to new changes that arise in retinal cells before birth or soon after. These changes happen inside the body and are not caused by ordinary day-to-day choices.
Older paternal age, and sometimes older maternal age, has been linked in some studies to a slightly higher chance of new cell changes. The increase appears small, and age alone does not mean a child will develop retinal cell cancer.
High-dose ionizing radiation during pregnancy can damage developing cells and may raise the chance of cancer-related changes. This kind of exposure is uncommon, and medical care is usually planned to keep radiation as low as possible.
Genetic risk factors
Most retinal cell cancer, also called retinoblastoma, is linked to changes in a gene called RB1 that normally helps keep cell growth under control. Some risk factors are inherited through our genes. Other genetic changes happen for the first time in a child, often before birth, even when no one else in the family is affected. The main genetic risk factors for retinal cell cancer help explain why the disease may affect one eye or both eyes.
RB1 changes: Most retinal cell cancers start after both working copies of the RB1 gene are lost or altered in retinal cells. Without that growth-control signal, immature eye cells can keep dividing when they should stop.
Inherited RB1: Some children are born with one altered RB1 copy in all of their cells because it was passed down from a parent. Carrying a genetic change doesn’t guarantee the condition will appear. But this inherited form greatly raises the chance of retinal cell cancer and often affects both eyes.
New RB1 mutation: Many children with retinal cell cancer have no family history because the RB1 change happened for the first time in the egg, sperm, or very early after conception. This can still create a heritable form, even when neither parent has the disease.
Family history: Having a parent, sibling, or other close relative with retinal cell cancer or a known RB1 change increases a child's risk. Families in this situation are often offered genetic counseling and testing to clarify who else may carry the same change.
MYCN change: A small number of retinal cell cancers are driven by extra copies of a gene called MYCN rather than RB1. This rare form is usually not inherited and more often affects one eye.
Lifestyle risk factors
For retinal cell cancer, lifestyle habits do not cause the tumor, but they can influence treatment tolerance, vision protection, recovery, and the risk of complications. When people ask about lifestyle risk factors for retinal cell cancer, the more accurate question is how lifestyle affects retinal cell cancer during care and follow-up. Daily habits are most relevant for protecting the remaining vision, supporting overall health during treatment, and lowering avoidable strain on the eyes and body.
Missing eye exams or treatment visits can allow tumor activity or treatment complications to go unnoticed for longer. Keeping scheduled follow-up is central to preserving vision and detecting recurrence or spread as early as possible.
Poor use of protective eyewear raises the chance of injury to a vulnerable eye, especially if vision is already reduced or one eye has been removed. Consistent eye protection can help prevent trauma and protect remaining visual function.
Smoking and secondhand smoke do not cause this cancer, but they can worsen healing, increase inflammation, and add stress to eye and vascular health during treatment. Avoiding tobacco may support recovery and reduce complications from surgery or other therapies.
Poor nutrition can make it harder to maintain strength, support healing, and cope with cancer treatment. A balanced diet with enough calories, protein, and micronutrients may help recovery and general resilience during care.
Risk prevention
For retinal cell cancer, often called retinoblastoma, true prevention is usually not possible because many cases start from a gene change present very early in life. In families with an inherited form, the main goal is to lower risk through genetic counseling, early testing, and fast eye checks so treatment can begin as soon as possible. Some prevention is universal, others are tailored to people with specific risks. This matters because the early symptoms of retinal cell cancer can be easy to miss at first, such as a white glow in the pupil or an eye that seems to wander.
If retinoblastoma runs in the family, genetic counseling can help clarify a child’s risk before or soon after birth. Testing may identify who needs close eye monitoring and who does not.
Babies and young children at higher risk need regular eye exams by an eye specialist, often starting soon after birth. Catching retinal cell cancer early can greatly improve the chance of saving sight and treating the tumor before it spreads.
Brothers, sisters, and sometimes parents may also need assessment when an inherited gene change is possible. This helps find retinal cell cancer or related risks early, even before obvious symptoms appear.
A white pupil in photos, crossed eyes, or new vision concerns should be checked quickly. Fast evaluation can lead to earlier diagnosis, which is the most effective way to reduce harm from retinal cell cancer.
Can you prevent Retinal cell cancer?
Usually, no, retinal cell cancer cannot be prevented. Most cases happen because of gene changes that are present from birth or develop very early in life, not because of diet, screen time, or other everyday habits. If this cancer runs in your family, genetic counseling and early eye checks cannot prevent it, but they can help find it as early as possible.
Transmission
Retinal cell cancer is not contagious, so it cannot be spread from one person to another through close contact, coughing, kissing, blood, or shared food. In children, this cancer is often known medically as retinoblastoma, and some cases happen because of a gene change that is passed from a parent to a child.
Other cases start as a new gene change in the child and are not inherited from either parent, so how retinal cell cancer is inherited can vary from family to family. If retinal cell cancer is linked to an inherited gene change, future children may also be at higher risk, which is why genetic counseling can be helpful.
When to test your genes
Genetic testing is most important if retinoblastoma is suspected, especially in babies and young children, if both eyes are affected, if there are multiple tumors, or if anyone in the family has had it. Results can guide eye exams, screening for relatives, and long-term follow-up.
Diagnosis
Retinal cell cancer is usually suspected when a child develops eye changes such as a white glow in the pupil in photos, an eye that seems to wander, or vision problems. Early and accurate diagnosis can help you plan ahead with confidence. The diagnosis of retinal cell cancer is based on a careful eye exam and imaging tests, and genetic testing may also be offered because some cases are linked to an inherited change.
An eye specialist usually examines the inside of the eye after widening the pupil with drops. In young children, this is often done under anesthesia so the doctor can get a clear, detailed look for tumors in both eyes.
Ultrasound of the eye can show a mass and tiny calcium deposits that are common in retinal cell cancer. MRI scans help show the size and spread of the tumor and are often used in the diagnosis of retinal cell cancer because they avoid radiation.
Doctors ask about symptoms, pregnancy and birth history, and whether anyone in the family has had retinoblastoma or another early eye cancer. Family history is often a key part of the diagnostic conversation when an inherited form is possible.
A blood test may look for a change in the RB1 gene, which is linked to many cases of retinoblastoma. This can help confirm the genetic diagnosis of retinal cell cancer, guide screening of the other eye, and clarify risks for brothers, sisters, or future children.
How is Retinal cell cancer diagnosed?
Retinal cell cancer, often called retinoblastoma, is usually diagnosed with a careful eye exam after the doctor uses drops to widen the pupils so they can clearly see the back of the eye. Doctors may also use imaging tests such as ultrasound or MRI to check the size of the tumor and whether it has spread, and young children often need medicine to help them sleep during the exam so they can stay still and safe. If retinoblastoma is suspected, a blood test may be used to look for an inherited gene change, which can help confirm the diagnosis and guide testing for family members.
Stages of Retinal cell cancer
In retinal cell cancer, doctors usually talk about stages based on how much of the eye is involved and whether the cancer has spread outside it. In children, this cancer is most often discussed using systems for retinoblastoma, which group disease from small tumors inside the eye to cancer that has spread elsewhere in the body. Early and accurate diagnosis helps you plan ahead with confidence. Sometimes the early symptoms of retinal cell cancer are subtle, such as a white glow in the pupil on a photo or an eye that seems to turn inward.
Stage 1
The cancer is only inside the retina or nearby parts of the eye. Vision may be affected little or not at all at first. Treatment often aims to save both life and as much sight as possible.
Stage 2
The cancer is still within the eye but is larger or more extensive. Many living with retinal cell cancer may have more obvious eye changes, such as poor vision, redness, or eye drifting. In some cases, saving the eye becomes harder.
Stage 3
The cancer has spread outside the eye to nearby tissues, the eye socket, or nearby lymph nodes. This is more serious and usually needs stronger treatment, often combining chemotherapy with surgery or radiation.
Stage 4
The cancer has spread to distant parts of the body, such as the brain, bone marrow, or bones. At this stage, treatment focuses on controlling disease throughout the body as quickly as possible.
Outlook and prognosis
The outlook for retinal cell cancer is often very good when it is diagnosed early and treated promptly, with survival rates for disease confined to the eye exceeding 95% in many high-income countries. Prognosis is less favorable if the tumor has spread outside the eye, to the brain, bone marrow, or other parts of the body, where treatment becomes more difficult and the risk of death rises substantially. Vision outcomes vary widely and depend on the tumor’s size, location, whether one or both eyes are affected, and whether eye-sparing treatment is possible. Children with an inherited form also need long-term follow-up because they have a higher risk of developing additional cancers later in life. Globally, mortality is much higher in places where diagnosis and specialist care are delayed, making early detection one of the most important factors for both survival and preserving sight.
Long-term effects
For many, the long-term effects of retinal cell cancer depend on how much of the eye was affected, whether treatment was needed in one or both eyes, and whether the cancer was linked to an inherited gene change. Some people do very well after treatment, while others live with lasting changes in vision, eye appearance, or eye health. Long-term effects vary widely, and children treated early often have a better outlook for vision and overall health. People with the inherited form also need closer follow-up over time because their risks can extend beyond the eye.
Reduced vision can last long term, especially if the tumor involved the center of sight or if treatment caused scarring in the retina. Some may have trouble with depth perception, reading small print, or judging distances, particularly if one eye sees much better than the other.
If one eye had to be removed to control retinal cell cancer, long-term effects can include permanent loss of vision on that side and changes in side vision. Many children adapt well, but the prosthetic eye may need replacement or adjustment as they grow.
Treatment can sometimes affect how the eye looks or moves, and the area around the eye may grow differently over time. This can be more noticeable after surgery or radiation, especially during childhood when the face is still developing.
Some treatments raise the chance of cataracts, dry eye, or irritation years later. These problems may blur vision or make the eye feel uncomfortable, and they can need ongoing eye care.
How is it to live with Retinal cell cancer?
Living with retinal cell cancer, usually called retinoblastoma, often means that daily life becomes centered around frequent eye exams, treatment visits, and watching closely for changes in vision, comfort, or how a child is using the affected eye. For many families, this can bring stress, disrupted routines, and worry about sight, appearance, and future health, but many children go on to do well with early treatment and careful follow-up. It also affects the people around them, because parents and caregivers often take on extra medical, emotional, and practical responsibilities, while siblings may need support as the family adjusts to appointments, uncertainty, and recovery.
Treatment and drugs
Treatment for retinal cell cancer depends on the size and location of the tumor, whether one or both eyes are affected, and whether the cancer has spread, but the main goals are to save life first and preserve vision when possible. Many people with retinal cell cancer are treated with chemotherapy, which uses cancer-fighting medicines to shrink the tumor, and this may be given into a vein, by mouth, into the eye, or through a blood vessel feeding the eye in some centers. Treatment plans often combine several approaches, including laser treatment, freezing treatment, heat treatment, radiation, or surgery to remove the eye if the cancer is large or painful and cannot be controlled safely in other ways. Doctors also treat problems linked to care, such as pain, nausea, or infection risk, and children often need regular eye exams during and after treatment to check how well it is working. Finding the right therapy can take some time, and early treatment for retinal cell cancer gives the best chance of protecting health and, when possible, sight.
Can you cure Retinal cell cancer?
Retinal cell cancer can often be cured, especially when it is found early and treated quickly. Treatment may include medicine to shrink the cancer, laser or freezing treatment, radiation, or sometimes surgery, and the goal is to save the child’s life first and protect vision when possible. If the cancer has spread outside the eye, cure can be harder, but treatment can still help control the disease.
Non-drug treatment
Retinal cell cancer can affect sight quickly, so treatment often focuses on saving life first, then protecting the eye and vision whenever possible. In children, care is usually planned by a team that includes eye cancer specialists, pediatric cancer doctors, and surgeons. Managing this condition often means combining local treatments for the tumor with close follow-up, since early treatment for retinal cell cancer can improve the chance of preserving vision.
A focused laser can seal blood vessels feeding the tumor or directly heat and damage small tumors. It is most often used for limited disease or together with other treatments to help spare the eye.
Cryotherapy destroys small tumors by freezing them from the outside of the eye. It is usually used for tumors near the edge of the retina and may be repeated over more than one session.
Gentle heat, also called thermotherapy, can shrink small tumors or treat areas that remain after other treatment. It is often paired with laser treatment or radiation to improve control.
Radiation can target the tumor when local treatments alone are not enough or when doctors are trying to avoid removing the eye. This may be given from outside the body or by placing a small radioactive plaque near the tumor for a short time.
Your genes may have an impact on how drugs work for you
For people living with retinal cell cancer, small inherited differences in the body can sometimes change how cancer medicines are broken down, which may affect how well treatment works or how likely side effects are. In real life, this can mean one child may do well with a usual treatment plan, while another may need closer monitoring or dose changes because of stronger side effects or a weaker response. These gene-based drug effects are not the main factor for most people with this eye cancer, but the care team may think about them when choosing treatment and watching how the body handles it.
Pharmacological treatments
Treatment for retinal cell cancer often aims to save the child’s life first, then protect the eye and vision when possible. The medicines used depend on how far the cancer has spread and whether it is inside the eye, in both eyes, or has come back after treatment. Many people know this cancer by its medical name, retinoblastoma. Not everyone responds to the same medication in the same way.
Doctors often use carboplatin, vincristine, and etoposide together when retinal cell cancer affects one or both eyes or when they need to shrink tumors before local treatment. These medicines are usually given into a vein in cycles over time.
Melphalan is a common drug for intra-arterial chemotherapy, where medicine is sent directly into the artery that feeds the eye. Topotecan or carboplatin may be added in some cases to improve tumor control while limiting treatment to the rest of the body.
Melphalan is often used for intravitreal chemotherapy, which means a very small dose is injected into the eye. Topotecan may also be used, especially when there are cancer cells floating in the eye, a problem often seen in advanced or early symptoms of retinoblastoma progression.
If retinal cell cancer has spread outside the eye, doctors may use stronger multi-drug chemotherapy combinations that can include vincristine, etoposide, carboplatin, cyclophosphamide, or cisplatin. These are more intensive treatments and are usually managed by a pediatric cancer team.
Genetic influences
When a baby or young child is diagnosed with retinal cell cancer, medically known as retinoblastoma, one of the first questions families have is whether it is inherited. It’s natural to ask whether family history plays a role. Most cases of retinal cell cancer are linked to a change in a gene called RB1, which normally helps keep retinal cells from growing out of control. Sometimes this change is present in all of the child’s cells because it was inherited from a parent or happened very early after conception, and these children are more likely to develop tumors in both eyes and may pass the risk on later in life. In other children, the gene change happens only in the retinal cells that formed the tumor, so there may be no family history and the chance of the condition affecting close relatives is much lower. Because this can change who else in the family may need screening, a genetics evaluation and testing are often part of care after retinal cell cancer is found.
Is Retinal cell cancer genetic?
Genetics are very important in retinal cell cancer. Changes in the RB1 gene cause many cases, especially in children, and inherited changes can raise risk, affect both eyes, and matter for family testing and future planning.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal and common part of human biology in the general population. Most of them do not directly affect health and simply reflect natural human diversity. For many genes, having a variant connected with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-understood variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For families facing retinal cell cancer, genetic testing can help doctors choose treatments that aim to control the tumor while protecting as much vision as possible. Not every difference in response is genetic, but a change in the RB1 gene often shapes care in a major way. When this gene change is inherited, many living with retinal cell cancer have a higher chance of tumors in both eyes and a higher risk of certain later cancers, so doctors may try to limit treatments such as radiation when safer options are available. This is one reason why treatment may lean toward carefully targeted chemotherapy, laser treatment, freezing treatment, or medicine delivered directly into the artery of the eye or into the eye itself.
Genetics also affects follow-up after treatment. Children with an inherited RB1 change usually need closer eye exams and longer-term monitoring than those whose tumor happened only in the eye. When people ask about the early symptoms of retinal cell cancer or why one child needs a different plan than another, the answer is often that the cancer’s genetic cause can change both the treatment approach and the long-term safety plan. For now, drug-response genetic testing plays a smaller role than RB1 testing, so doctors usually base medicine choices on the child’s age, the tumor’s size and location, and whether the gene change is inherited.
Interactions with other conditions
For families already dealing with eye problems in a young child, retinal cell cancer can sometimes overlap with other serious conditions, which may change follow-up care. In hereditary retinal cell cancer, also known medically as retinoblastoma, the same gene change can raise the risk of other cancers later on, especially bone cancers, soft tissue cancers, melanoma, and in some children a related brain tumor called pineoblastoma. Doctors call it a comorbidity when two conditions occur together. This is why children with inherited retinoblastoma often need long-term cancer screening even after the eye tumor has been treated.
Retinal cell cancer can also be mistaken at first for other eye diseases that cause a white pupil, poor vision, or eye turning, so doctors may need to rule out problems such as severe infection, retinal detachment, or certain birth-related eye conditions. Someone might notice their symptoms flare when another condition is active. Treatment can also affect how other illnesses are managed, since chemotherapy, radiation, or surgery may change infection risk, hearing, growth, or vision needs over time.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Retinal cell cancer?
Several eye problems can look like retinal cell cancer, especially in children, including a cataract, which is clouding of the lens, a detached retina, severe infection or swelling inside the eye, and sometimes crossed eyes that first draw attention to a vision problem. One of the most common look-alikes is Coats disease, where abnormal blood vessels leak in the back of the eye and can cause a white glow in the pupil or poor vision, much like retinal cell cancer.
History
Long before doctors could see the inside of the eye clearly, families sometimes noticed a strange white glow in a child’s pupil in certain light, or that one eye seemed to drift. What we now call retinal cell cancer, more commonly known medically as retinoblastoma, was first described in the medical literature in the 1800s, when physicians began linking these signs to a tumor growing in the retina, the light-sensitive tissue at the back of the eye.
At first, understanding was limited. Doctors could describe what they saw, but they had few tools to confirm the diagnosis early, and treatment options were harsh. In many cases, the affected eye had to be removed to save the child’s life. As medical science evolved, specialists learned that retinoblastoma could sometimes affect one eye and sometimes both, and they became better at separating it from other causes of eye changes in infants and young children.
The 20th century brought major progress. Better eye exams, imaging, and pathology helped doctors recognize retinal cell cancer sooner, often before it had spread beyond the eye. Over time, radiation and later chemotherapy gave some children a chance to keep the eye, and sometimes useful vision, especially when the cancer was found early. For many families, this changed the experience from an urgent fight simply to survive into a more hopeful effort to treat the cancer while preserving sight when possible.
Researchers also came to understand that some cases were linked to an inherited tendency, while others were not. That insight helped explain why retinoblastoma can run in some families and why brothers, sisters, or future children may sometimes need screening even if they seem well. Knowing this history helps explain why eye specialists now take early warning signs seriously, including a white pupil in photos or a new crossed eye.
Today, the history of retinal cell cancer is also a story of earlier diagnosis and much better outcomes. In countries where children can be seen quickly by eye and cancer specialists, most survive, and many keep one or both eyes. Even so, the history of retinoblastoma still shapes care today: parents are taught the early symptoms of retinal cell cancer, doctors look for it promptly, and follow-up remains an important part of protecting both health and vision.